VentriPoint Diagnostics Valuation
| VPTDF Stock | USD 0.07 0.01 6.67% |
VentriPoint Diagnostics seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of VentriPoint Diagnostics from inspecting the company fundamentals such as Shares Owned By Insiders of 1.75 %, return on equity of -1.35, and Current Valuation of 28.27 M as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that VentriPoint Diagnostics' price fluctuation is out of control at this time. Calculation of the real value of VentriPoint Diagnostics is based on 3 months time horizon. Increasing VentriPoint Diagnostics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the VentriPoint pink sheet is determined by what a typical buyer is willing to pay for full or partial control of VentriPoint Diagnostics. Since VentriPoint Diagnostics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of VentriPoint Pink Sheet. However, VentriPoint Diagnostics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.07 | Real 0.0653 | Hype 0.07 | Naive 0.0689 |
The real value of VentriPoint Pink Sheet, also known as its intrinsic value, is the underlying worth of VentriPoint Diagnostics Company, which is reflected in its stock price. It is based on VentriPoint Diagnostics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of VentriPoint Diagnostics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of VentriPoint Diagnostics helps investors to forecast how VentriPoint pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of VentriPoint Diagnostics more accurately as focusing exclusively on VentriPoint Diagnostics' fundamentals will not take into account other important factors: VentriPoint Diagnostics Total Value Analysis
VentriPoint Diagnostics is at this time forecasted to have takeover price of 28.27 M with market capitalization of 32.09 M, debt of 125.38 K, and cash on hands of 7.29 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the VentriPoint Diagnostics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
28.27 M | 32.09 M | 125.38 K | 7.29 M |
VentriPoint Diagnostics Asset Utilization
One of the ways to look at asset utilization of VentriPoint is to check how much profit was generated for every dollar of assets it reports. VentriPoint Diagnostics has a negative utilization of assets of -0.64 %, losing $0.006381 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of VentriPoint Diagnostics shows how discouraging it operates for each dollar spent on its assets.VentriPoint Diagnostics Ownership Allocation
VentriPoint Diagnostics shows a total of 156.51 Million outstanding shares. About 98.25 % of VentriPoint Diagnostics outstanding shares are held by general public with 1.75 (%) owned by insiders and only 0.0 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.VentriPoint Diagnostics Profitability Analysis
Net Loss for the year was (3.88 M) with loss before overhead, payroll, taxes, and interest of (6.27 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates VentriPoint Diagnostics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in VentriPoint Diagnostics and how it compares across the competition.
About VentriPoint Diagnostics Valuation
The pink sheet valuation mechanism determines VentriPoint Diagnostics' current worth on a weekly basis. Our valuation model uses a comparative analysis of VentriPoint Diagnostics. We calculate exposure to VentriPoint Diagnostics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of VentriPoint Diagnostics's related companies.Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company was incorporated in 2004 and is based in Toronto, Canada. Ventripoint Diagnostics is traded on OTC Exchange in the United States.
8 Steps to conduct VentriPoint Diagnostics' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates VentriPoint Diagnostics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct VentriPoint Diagnostics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain VentriPoint Diagnostics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine VentriPoint Diagnostics' revenue streams: Identify VentriPoint Diagnostics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research VentriPoint Diagnostics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish VentriPoint Diagnostics' growth potential: Evaluate VentriPoint Diagnostics' management, business model, and growth potential.
- Determine VentriPoint Diagnostics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate VentriPoint Diagnostics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
VentriPoint Diagnostics Growth Indicators
Investing in growth stocks can be very risky. If the company such as VentriPoint Diagnostics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 155.6 M | |
| Retained Earnings | -43.7 M |
Complementary Tools for VentriPoint Pink Sheet analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |